Bluejay Diagnostics (BJDX) Shares Outstanding (Diluted) (2021 - 2026)
Bluejay Diagnostics (BJDX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 393.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 968.53 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 873.00 Mn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 984,668.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 984,668.00 |
| Dec 31, 2025 | 449,043.00 |
| Sep 30, 2025 | 393,634.00 |
| Jun 30, 2025 | 346,780.00 |
| Mar 31, 2025 | 138,503.00 |
| Dec 31, 2024 | 45,848.00 |
| Sep 30, 2024 | 47,779.00 |
| Jun 30, 2024 | 2,416.00 |
| Mar 31, 2024 | 1,475.00 |
| Dec 31, 2023 | 685.00 |
| Sep 30, 2023 | 689.00 |
| Jun 30, 2023 | 639.00 |
| Mar 31, 2023 | 637.00 |
| Dec 31, 2022 | 630.00 |
| Sep 30, 2022 | 630.00 |
| Jun 30, 2022 | 630.00 |
| Mar 31, 2022 | 629.00 |
| Dec 31, 2021 | 266.00 |
| Sep 30, 2021 | 328.00 |
| Jun 30, 2021 | 131.00 |